Aspartate Aminotransferase (AST) more
than Alanine Aminotransferase (ALT) Levels Predict the Progression of Liver Fibrosis in Chronic
HCV Infection
Stránský J.1, Rýzlová M.1, Stříteský J.2, Horák J.1
1I. interní klinika 3. lékařské fakulty UK a FN KV, Praha, přednosta prof. MUDr. Jiří Horák, CSc. 2Ústav patologie 3. lékařské fakulty UK a FN KV, Praha, přednosta doc. MUDr. Václav Mandys, CSc. |
|
Summary:
The development and severity of liver fibrosis in patients with chronic HCV infection can be
evaluated best according to the staging of fibrosis in blind liver biopsy. So far there is however no
biochemical indicator suggesting advanced fibrosis or progression of fibrosis in chronic HCV
infection. In 1997 - 1999 60 adult out-patients (32 women) with chronic HCV infection were examined
by blind liver biopsy. The grading of hepatitis was scored according to Knodell and staging of
fibrosis according to Desmet. All patients were anti-HCV positive, assessed by the ELISA-3 method
and 48/60 had positive HCV RNA in serum. The main risk factor of HCV infection was blood
transfusion (67 %). Of 27 examined patients 20 (74 %) had serotype HCV 1. Staging of fibrosis:
histologically confirmed fibrosis was not recorded in 11 patients (18.3 %), mild and medium fibrosis
was recorded in 25 (42 %), severe fibrosis in 14 (23 %) and cirrhosis in 10 (17 %). With confirmed
fibrosis correlated more closely AST serum activity (p < 0.002) than ALT activity (p < 0.03). Steatosis
of the liver was found in 25 (42 %) patients. The mean age of patients with steatosis was
significantly higher than that of patients without steatosis (p < 0.0008). Steatosis was more frequent
in patients with fibrosis (p < 0.04), in particularin the age group above 60 years. The development
of fibrosis in patients with chronic HCV infection is suggested by permanently elevated
activity of both transaminases whereby AST has a higher predictive value than ALT activity.
A total of 40% histologically tested patients had the highest staging of fibrosis (3 - 4). Steatosis is
in chronic HCV infection a very frequent finding (42 %), in particular in patients above 60 years
and those with serious fibrosis. The finding of fibrosis should stimulate the initiation of antiviral
treatment which can lead to regression of fibrosis and improvement of the histological finding.
Key words:
Chronic HCV infection - Liver biopsy - Fibrosis - Steatosis - Cirrhosis - Interferon
treatment
|